U.S. patent 5156834: Antiperspirant compositions. Granted to Beckmeyer et. al. (3 total) on 1992-10-20 (filed 1989-07-03) and assigned to The Procter & Gamble Company. Currently involved in at least 1 patent litigation: Luka v. The Proctor and Gamble Company (Illinois). See http://news.priorsmart.com for more info.
U.S. patent 5156834: Antiperspirant compositions. Granted to Beckmeyer et. al. (3 total) on 1992-10-20 (filed 1989-07-03) and assigned to The Procter & Gamble Company. Currently involved in at least 1 patent litigation: Luka v. The Proctor and Gamble Company (Illinois). See http://news.priorsmart.com for more info.
U.S. patent 5156834: Antiperspirant compositions. Granted to Beckmeyer et. al. (3 total) on 1992-10-20 (filed 1989-07-03) and assigned to The Procter & Gamble Company. Currently involved in at least 1 patent litigation: Luka v. The Proctor and Gamble Company (Illinois). See http://news.priorsmart.com for more info.
HUA
IA
. "USOOS136835A,
United States Patent 19 fx) Patent Number: 5,156,834
Beckmeyer et al. ls] Date of Patent: Oct. 20, 1992
[58] ANTIPERSPIRANT COMPOSITIONS 4065564 12/1977 Miles, Jr eta sn4yo6
SOTSEEO 2/197E. Pade weennnnn ayes
[75] Inventors: Mary V. Beckmeyer; James A. Davis; 4,083,956 4/1978 Shelton. 424/66
Gary R. Kelm, al of Cincinnati, Ohio 4122029 10/1978 Gee eta. 252/309
2126699 N96 Davy etal 424/56
173] Assignee: The Procter & Gamble Company, 4151272 “4/1979. Geary era aaa
‘Cincinnati, Ohio 4,152,816 5/1979 Spitzer et Al. eomiensnnmarrnn 424/68
BBN) Appl. Nos 371-783 4194366 11/1979 Spicer eta aan
(22) Filed: Jul, 3, 1989 FOREIGN PATENT DOCUMENTS
asst
2018590 10/1979. United Kingdom
Related U.S, Application Data
a OTHER PUBLICATIONS
{63} Continuation of Ser. No. 693,420, Jan 22,198, aban
Gonsd, whch i a continuation of Ser No. 163903, Todd etal. Amer. Perf, Cosm, Oct, 1971
Sion 30,1950 abandoned, whichs s cominuationine Dow Corning New Product Bulletin Formulation
par of Ser No, 2.13, Nov. 7, 1979, abandoned” E2-9031, Aug. 1973
Todd et sl, Cosmetics & Toiletries, Jan. 1976, vol. 91,
[51] Incas AGIK 7/93; AGIK 7/34, OAL eta;
‘AGIK 1/36; AGIK 7/38 r
maken (35, AGIK 1/38 Drug & Cosmetic Industry, Nov. 1978 vol. 1, p. 122.
124766, 424/67, 426/68 Primary Examiner—Dale R. Ore
{55} Field of Search 424/65, 68, 47 Automey, Agent, or Firm-—Douglas C. Moh!
(5 References Cited 57) ABSTRACT
US. PATENT DOCUMENTS Antiperspirant compositions comprising a particulate
poets aasyiea amtiperspirant material, 2 bulking/suspending agent, a
its Sans aatt “veg volatile silicone and @ non-volatile emollient,
40825381 10/1977 Pager eta aes
‘40541670 10/1977 Bubler 224/358 9 Claims, No Drawings5,156,834
1
ANTIPERSPIRANT COMPOSITIONS
CROSS REFERENCE TO RELATED
‘APPLICATION
This is a continuation of application Ser. No. 693,420
filed on Jan. 22, 1985, now abandoned, which is a con-
tinuation of Ser. No. 163,903, filed Jun. 30, 1980, now
abandoned, which is a continuation-in-part of our co-
pending application Ser. No. 092,113, filed Nov. 7,
1979, now abandoned,
TECHNICAL FIELD
‘This invention relates to novel antiperspirant compo-
sitions which are useful in a variety of dispensing de-
vices. The compositions comprise an_antiperspirant
‘material, a bulking/suspending agent, a volatile silicone
and 8 non-volatile emollient,
BACKGROUND ART
‘The use of volatile silicones and non-volatile emol-
lients in a variety of compositions has been suggested,
References disclosing such compositions include U.S.
Pat. Nos. 3,836,647, Sep. 17, 1974 to Lange; 3,903,258,
Sep. 2, 1975 to Siegal, 4,053,581, Oct. 11, 1977 to Pader
tet al; 4,054,670, Oct. 18, 1977 to Bubler; 4,065,564, Dec.
21, 1977 to Miles, Jr. et ak; 4,073,880, Feb. 14, 1978 to
Pader et al; 4,083,956, Apr. 1, 1978 to Shelton; and
4,122,029, Oct. 24, 1978 to Gee et al.
Although the above-listed references describe a vari-
ety of compositions, they do not describe or suggest
‘compositions similar to those of the present invention.
Furthermore, the references do not suggest the surpris-
ing improvement in antiperspirant efficacy found with 3
the present invention.
“Accordingly, itis an object of the present invention
to provide antiperspirant compositions having en-
hanced antiperspirant efficacy
tis @ further object of the present invention to pro-
vide antiperspirant compositions which are suitable for
‘use in a number of dispensing devices
DISCLOSURE OF THE INVENTION
‘The present invention relates to antiperspirant com
positions comprising particulate antiperspirant mate
Tial, a bulking/suspending agent, a volatile silicone and
‘a non-volatile emollient. The compositions are in the
form of suspensions and are preferably anhydrous (con-
taining less than about 1.5% water).
‘The particulate antiperspirant material comprises
from about 10% to 70%, preferably from about 15% 10
60%, by weight of the composition.
‘The bulking/suspending agent comprises from about
19% to 15%, preferably from about 2% 10 8%, by
‘weight of the composition.
“The volatile silicone comprises from about 10% to
80%, preferably from about 15% to 70%, by weight of
the composition.
‘The non-volatile emollient comprises from about 19%
10 35%, preferably from about 5% to 30%, by weight of
the composition.
DETAILED DESCRIPTION OF THE,
INVENTION
‘The necessary 2s well as optional components of the
‘present compositions are described in detail below.
20
2
45
o
6
2
ANTIPERSPIRANT MATERIAL
‘The present compositions contain from about 10% to
10%, preferably 15% to 60%, by weight of a particul-
tate antiperspirant material. Such materials include for
example, many aluminum or zirconium astringent salts
for complexes and are well known in the antiperspirant
art.
‘Any aluminum astringent antiperspirant salt or alumi-
num and/or zirconium astringent complex in particulate
form can be employed herein. Salts useful as astringent
antiperspirant salts or as components of astringent com-
plexes include sluminum halides, aluminum hydroxyha-
lides, zirconyl oxyhalides, zirconyl hydroxyhalides and
‘mixtures of these salt materials.
“Aluminum salts of this type include aluminum chlo-
ride and the aluminum hydroxyhalides having the gen-
eral formula Alz (OH),QyXH20 where Q is chlorine,
bromine or iodine; where x is 2 to $ and x+y=6 and x
and y do not need to be integers, and where X is about
1 to 6. Aluminum salts of this type can be prepared in
the manner described more fully in Gilman, U.S. Pat.
No. 3,887,692, issued Jun. 3, 1975, and U.S. Pat. No.
3,904,741, Sep. 9, 1975 to Jones and Rubino incorpo-
rated herein by reference
‘The zirconium compounds which are useful in the
present invention include both the zirconium oxy salts
and zirconium hydroxy salts, also referred to as the
irconyl salts and zirconyl hydroxy salts. These com-
pounds may be represented by the following general
‘empirical formula:
ZrO10H) Be
wherein z may vary from about 0.9 to 2 and need not be
an integer, n is the valence of B, 2-nz is greater than or
‘equal t0 0, and B may be selected form the group con-
sisting of halides, nitrate, sulfamate, sulfate and mixtures
thereof. Although only zirconium compounds are ex-
emplified in this specification, it will be understood that
other Group IV B metal, including hafnium could be
used in the present invention.
‘AS with the basic aluminum compounds, it will be
understood that the above formula is greatly simplified
and is intended to represent and include compounds
having coordinated and/or bound water in various
quantities, as well as polymers, mixtures and complexes
of the above. As will be seen from the above formula,
the zirconium hydroxy salts actually represent a range
‘of compounds having various amounts of the hydroxy
group, varying from about 1.1 to only slightly greater
than O groups per molecule.
Several types of antiperspirant complexes utilizing
the above antiperspirant salts are known in the art. For
example Luedders et al; U.S. Pat. No. 3,792,068, issued
Feb, 12, 1974 discloses complexes of aluminum, zirco-
nium and amino acids such as glycine. Complexes such
as those disclosed in this Luedders et al °068 patent and
other similar complexes are commonly known as ZAG.
ZAG complexes are chemically analyzable for the pres-
ence of aluminum, zirconium and chlorine. ZAG com=
plexes useful herein are identified by the specification of
both the molar ratio of aluminum to zirconium (herein-
after “ALZr” ratio) and the molar ratio of total metal to
chlorine (hereinafter “Metal:Cl" ratio). ZAG com-
plexes useful herein have an Al:Zr ratio of from about
167 to 12.5 and a Metall ratio of from about 0.73 to
193.5,156,834
3
Preferred ZAG complexes are formed by
(A) Co-dissolving in water
(i) one part Al; (OH)snQm, Wherein Q is an anion
selected from the group consisting of chloride,
bromide and iodide and m is a number from s
about 0.8 to about 2.0;
@) x paris ZrO(OH)2